Norinchukin Bank’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-20,826
Closed -$3.83M 550
2021
Q2
$3.83M Buy
20,826
+455
+2% +$83.6K 0.06% 175
2021
Q1
$3.12M Buy
20,371
+979
+5% +$150K 0.04% 196
2020
Q4
$3.03M Sell
19,392
-118
-0.6% -$18.4K 0.04% 180
2020
Q3
$2.23M Buy
19,510
+447
+2% +$51.2K 0.04% 209
2020
Q2
$2.14M Sell
19,063
-202
-1% -$22.7K 0.04% 201
2020
Q1
$1.73M Sell
19,265
-10,705
-36% -$961K 0.03% 208
2019
Q4
$3.24M Sell
29,970
-3,087
-9% -$334K 0.04% 238
2019
Q3
$3.24M Buy
33,057
+814
+3% +$79.7K 0.05% 249
2019
Q2
$4.22M Sell
32,243
-10,809
-25% -$1.42M 0.06% 187
2019
Q1
$5.82M Buy
43,052
+1,548
+4% +$209K 0.07% 175
2018
Q4
$4.04M Buy
41,504
+12,841
+45% +$1.25M 0.06% 205
2018
Q3
$3.98M Buy
28,663
+3,453
+14% +$480K 0.05% 187
2018
Q2
$3.13M Buy
25,210
+4,898
+24% +$608K 0.05% 192
2018
Q1
$2.26M Buy
20,312
+2,450
+14% +$273K 0.04% 216
2017
Q4
$2.14M Buy
17,862
+1,249
+8% +$149K 0.04% 220
2017
Q3
$2.33M Buy
16,613
+1,029
+7% +$144K 0.05% 231
2017
Q2
$1.9M Buy
15,584
+989
+7% +$120K 0.04% 259
2017
Q1
$1.77M Buy
14,595
+992
+7% +$120K 0.04% 253
2016
Q4
$1.66M Buy
13,603
+1,597
+13% +$195K 0.04% 248
2016
Q3
$1.47M Buy
12,006
+257
+2% +$31.5K 0.04% 260
2016
Q2
$1.37M Buy
11,749
+187
+2% +$21.8K 0.03% 251
2016
Q1
$1.61M Buy
11,562
+1,035
+10% +$144K 0.04% 238
2015
Q4
$2.01M Sell
10,527
-2,412
-19% -$460K 0.05% 183
2015
Q3
$2.02M Buy
12,939
+263
+2% +$41.1K 0.05% 204
2015
Q2
$2.29M Buy
12,676
+691
+6% +$125K 0.06% 180
2015
Q1
$2.08M Buy
11,985
+301
+3% +$52.2K 0.05% 191
2014
Q4
$2.16M Buy
11,684
+3,742
+47% +$692K 0.05% 179
2014
Q3
$1.32M Buy
7,942
+561
+8% +$93K 0.04% 180
2014
Q2
$1.15M Sell
7,381
-805
-10% -$126K 0.03% 179
2014
Q1
$1.25M Buy
8,186
+863
+12% +$131K 0.04% 174
2013
Q4
$973K Sell
7,323
-21
-0.3% -$2.79K 0.03% 195
2013
Q3
$853K Buy
7,344
+585
+9% +$67.9K 0.02% 202
2013
Q2
$623K Buy
+6,759
New +$623K 0.02% 222